DAPHANY CONNOR: Open Payments
NPI 1942992532 · LANCASTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$870 in 22 payments from 8 companies in 2025. Trend: 2023 $258 · 2024 $478 · 2025 $870
Food & beverage: $870
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $319 |
| AstraZeneca Pharmaceuticals LP | 6 | $210 |
| Lilly USA, LLC | 3 | $188 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| Corcept Therapeutics | 1 | $25 |
| PFIZER INC. | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: MOUNJARO, AIRSUPRA, Ozempic, Wegovy, TRELEGY ELLIPTA, BREZTRI, Korlym, ELIQUIS.
Industry payments across CA — which companies pay providers there.
